MOTS-C 10MG

MOTS-c (Mitochondrial Open Reading Frame of the 12S rRNA type-c) is a 16-amino-acid mitochondrial-derived peptide (MDP) with the sequence MRWQEMGYIFYPRKLR. It is naturally encoded in the mitochondrial DNA (specifically a short open reading frame in the 12S rRNA region) and produced in response to metabolic stress, exercise, or fasting.

Unlike most peptides, it originates from the mitochondria (the cell’s energy powerhouses) and acts as a signaling molecule that communicates between mitochondria and the nucleus, influencing systemic metabolism.

How It Works

MOTS-c functions primarily as a metabolic regulator and exercise mimetic:

• AMPK activation: It increases levels of AICAR (an AMPK activator), turning on AMP-activated protein kinase — the “metabolic master switch” that promotes energy production, glucose uptake, and fat oxidation while inhibiting energy storage.
• Folate-AICAR-AMPK pathway: This leads to improved mitochondrial function, biogenesis (via PGC-1α and SIRT1), and metabolic flexibility.
• Insulin sensitivity and glucose handling: Enhances glucose utilization in skeletal muscle and reduces insulin resistance.
• Fat metabolism: Promotes lipolysis, fatty acid oxidation, browning of white fat, and reduces fat accumulation (especially in liver and adipose tissue).
• Nuclear gene regulation: Translocates to the nucleus to modulate gene expression related to stress response, inflammation, and aging.

It mimics many benefits of exercise and calorie restriction at the cellular level, helping maintain energy homeostasis under stress.

Potential Benefits and Why People Use It

In preclinical research (mostly animal and in-vitro studies) and emerging human interest, MOTS-c is explored for:

• Metabolic health and fat loss — Improves insulin sensitivity, boosts fat burning, reduces obesity, and targets visceral fat.
• Exercise performance and recovery — Enhances endurance, physical capacity (even in older models), muscle metabolism, and adaptation to training.
• Anti-aging and longevity — Supports mitochondrial function, reduces age-related decline, and may protect against metabolic diseases associated with aging.
• Additional effects — Potential benefits for inflammation reduction, bone metabolism, cardiovascular function, and cognitive health.

It is popular in fitness, bodybuilding, longevity, and regenerative communities as a “exercise in a vial” option, often stacked with other peptides for comprehensive metabolic and recovery support.

Important Caveats

• Limited human evidence: Strong preclinical data exists, but large-scale, long-term human clinical trials are lacking. Most benefits are demonstrated in animal models.
• Regulatory status: Not FDA-approved for any medical use. It is considered a research chemical and is on the FDA’s Category 2 bulk substances list (significant safety risks for compounding). Banned by WADA for athletes.
• Safety: Generally well-tolerated in studies with low toxicity in animals, but human data is limited. Anecdotal side effects include injection-site reactions, heart palpitations, insomnia, or fatigue. Theoretical concerns involve metabolic dysregulation or effects on homocysteine/folate pathways. Long-term safety is unknown.

Bottom line: MOTS-c is a fascinating mitochondrial peptide that has research potential to act as a potent metabolic regulator and exercise mimetic, with strong potential for improving insulin sensitivity, fat loss, energy metabolism, and healthy aging. For your PPR Scientific LLC, highlight its research-grade nature, include robust disclaimers, emphasize quality sourcing, and always stress the need for professional medical advice. As with your other offerings (BPC-157, TB-500, IGF-1 LR3, Tesamorelin, etc.), position it educationally in the experimental/research context.